ask="28.36"
ask_size="2500"
average_daily_volume="14386"
bid="20.19"
bid_size="2500"
book_value="0.00"
change="+1.18"
change_from_200_day_moving_average="0.08"
change_from_50_day_moving_average="1.11"
change_from_52_week_high="-3.03"
change_From_52_week_low="3.88"
change_in_percent="+5.30%"
close="23.44"
dividend_pay_date="1/4/2016"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="N/A"
ex_dividend_date="12/29/2015"
float_shares="N/A"
high="23.44"
high_52_weeks="26.47"
last_trade_date="2/27/2017"
last_trade_price="23.44"
last_trade_size="100"
last_trade_time="3:59pm"
low="22.28"
low_52_weeks="19.56"
market_capitalization="23.44B"
moving_average_200_day="23.36"
moving_average_50_day="22.33"
name="Loncar Cancer Immunotherapy ETF"
notes="N/A"
one_year_target_price="N/A"
open="22.28"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.33%"
percent_change_from_50_day_moving_average="+4.95%"
percent_change_from_52_week_high="-11.45%"
percent_change_from_52_week_low="+19.84%"
previous_close="22.26"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="1000000000"
short_ratio="0.00"
stock_exchange="NGM"
symbol="CNCR"
volume="16708"
weeks_range_52="19.56 - 26.47"
